References
- Zane LT, Leyden WA, Marqueling AL, Manos MM. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol 2006;142:1016–1022.
- Amalfitano G, Pernod G, Mallaret M, Barjhoux C, Berger F, Besson G et al. [Risk of intracerebral hematoma and profibrinolytic activity of isotretinoin]. Therapie 1995;50:479–481.
- Górnicki A, Gutsze A. In vivo and in vitro influence of etretinate on erythrocyte membrane fluidity. Eur J Pharmacol 2001;423:127–134.
- Herman DC, Dyer JA. Anterior subcapsular cataracts as a possible adverse ocular reaction to isotretinoin. Am J Ophthalmol 1987;103:236–237.
- Wenham CJ, Clarke I, Shun Shin GA. Isotretinoin-related optic disc swelling. Br J Hosp Med (Lond) 2005;66:644–645.
- Wu TT, Chuang CT, Sheu SJ, Chiou YH. Non-vitrectomizing vitreous surgery for premacular haemorrhage. Acta Ophthalmol 2011;89:194–197.
- Kooistra T, Opdenberg JP, Toet K, Hendriks HF, van den Hoogen RM, Emeis JJ. Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo. Thromb Haemost 1991;65:565–572.
- Moeller KE, Touma SC. Prolonged thrombocytopenia associated with isotretinoin. Ann Pharmacother 2003;37:1622–1624.